MultiCell Technologies Inc (MCET)

[redsox17]

New report examines the liver cancer H2 2015 pipeline review market H2 2015
This research provides comprehensive information on the therapeutic development for Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.





This research also reviews key players involved in the therapeutic development for Liver Cancer and special features on late-stage and discontinued projects. The research enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope of this research:
•The report provides a snapshot of the global therapeutic landscape of Liver Cancer
•The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
•The report reviews key players involved in the therapeutics development for Liver Cancer and enlists all their major and minor projects
•The report summarizes all the dormant and discontinued pipeline projects
•A review of the Liver Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
•Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
•A detailed assessment of monotherapy and combination therapy pipeline projects
•Coverage of the Liver Cancer pipeline on the basis of target, MoA, route of administration and molecule type
•Latest news and deals relating related to pipeline products

Complete research on H2 2015 pipeline review of Liver Cancer with 248 market data tables and 16 figures, spread across 1113 pages is available at http://www.rnrmarketresearch.com/liver-cancer-pipeline-review-h2-2015-market-report.html .

Companies: 4SC AG, AB Science SA, AbbVie Inc., Acceleron Pharma, Inc., ACROVIS Pharma AG, Adaptimmune Limited, Aduro BioTech, Inc., Advanced Accelerator Applications SA, Advenchen Laboratories, LLC, Alfact Innovation, Alnylam Pharmaceuticals, Inc., American Gene Technologies International Inc., Amgen Inc., AndroScience Corporation, APAvadis Biotechnologies Srl, Arbutus Biopharma Corporation, ArQule, Inc., Array BioPharma Inc., Arrowhead Research Corporation, Astex Pharmaceuticals, Inc., AstraZeneca Plc , AVEO Pharmaceuticals, Inc., Bayer AG, Bio-Cancer Treatment International Limited, BioCancell Ltd, Biogazelle, Bioneer Corporation,BioStar Pharmaceuticals, Inc., Blueprint Medicines, Boehringer Ingelheim GmbH, Boston Biomedical, Inc., Bristol-Myers Squibb Company, Caladrius Biosciences, Inc., Can-Fite BioPharma Ltd., CASI Pharmaceuticals Inc., CCRP Therapeutics GmbH, Celgene Corporation, Celldex Therapeutics, Inc., Celsion Corporation, China Medical System Holdings Limited, Chipscreen Biosciences Ltd, Chroma Therapeutics Limited, CohBar, Inc., CrystalGenomics, Inc., CytRx Corporation, CZ BioMed Corp, Delcath Systems, Inc., Dicerna Pharmaceuticals, Inc., Digna Biotech, S.L., Double Bond Pharmaceutical International AB, e-Therapeutics Plc, Eisai Co., Ltd., Eli Lilly and Company, Endocyte, Inc., Erytech Pharma SA, Eureka Therapeutics, Inc., Exelixis, Inc., F. Hoffmann-La Roche Ltd., Genelux Corporation, Genoscience Pharma, GenSpera, Inc., GlaxoSmithKline Plc, Golden Biotechnology Corp., HanAll Biopharma Co., Ltd., HEC Pharm Co., Ltd., Horizon Pharma Plc, Huperion Sarl, Immunicum AB, Immunitor, Inc., Immunomedics, Inc., Immunovative Therapies, Ltd., Immuron Limited, IMPACT Therapeutics, Inc., In-Cell-Art S.A.S., Incanthera Ltd., Incuron, LLC, InteRNA Technologies B.V., Jasco Pharmaceuticals, LLC., Jenrin Discovery, Inc., Johnson & Johnson, JSK Therapeutics Inc., KAHR medical Ltd., Keystone Nano, Inc., Kite Pharma, Inc., Komipharm International Co., Ltd., Kowa Company, Ltd., Les Laboratoires Servier SAS, Ligand Pharmaceuticals, Inc., LivTech, Inc., Lixte Biotechnology Holdings, Inc., Lytix Biopharma AS, MaxCyte, Inc., MedImmune, LLC, Medivation, Inc., Medivir AB, Merck KGaA, Merrimack Pharmaceuticals, Inc., Millennium Pharmaceuticals, Inc., Mirna Therapeutics, Inc., MolMed S.p.A., MultiCell Technologies, Inc., NeoPharm Co., Ltd., Nimbus Therapeutics, LLC, NormOxys, Inc., Northwest Biotherapeutics, Inc., Novartis AG, Nymox Pharmaceutical Corporation, Omeros Corporation, Omnitura Therapeutics Inc., Oncology Research International Limited, Oncolys BioPharma Inc., OncoMed Pharmaceuticals, Inc., OncoTherapy Science, Inc., Oneness Biotech Co., Ltd., Ono Pharmaceutical Co., Ltd., Onxeo SA, Onyx Pharmaceuticals, Inc., OPKO Health, Inc., Orega Biotech SAS, Otsuka Holdings Co., Ltd., Panacea Pharmaceuticals, Inc., Peptinov SAS, Peregrine Pharmaceuticals, Inc., Pfizer Inc., Pharma Mar, S.A., PharmAbcine, Inc., PharmaEssentia Corporation, PhaseRx, Inc., Phosplatin Therapeutics LLC, Polaris Pharmaceuticals, Inc., Progen Pharmaceuticals Limited, ProMetic Life Sciences Inc., Provecs Medical GmbH, Provectus Biopharmaceuticals, Inc., Qu Biologics Inc., Quimatryx, S.L., Raptor Pharmaceutical Corp., RedHill Biopharma Ltd., Regen BioPharma, Inc., Regulus Therapeutics Inc., Rigontec GmbH, Saronic Biotechnology, Inc., Savoy Pharmaceuticals, Inc., Shenogen Pharma Group Ltd., Silence Therapeutics Plc, Sillajen Biotherapeutics, Sirnaomics, Inc., Synovo GmbH, Synta Pharmaceuticals Corp., Taiwan Liposome Company, Ltd., Targetome, Therapure Biopharma Inc., Theravectys SA, Threshold Pharmaceuticals, Inc., Tiziana, Toko Pharmaceutical Industries Co., Ltd., TRACON Pharmaceuticals, Inc., Transgene Biotek Limited, Tumorend, LLC, VasGene Therapeutics, Inc., Vaxon Biotech, Vect-Horus S.A.S., Verlyx Pharma Inc., Vicus Therapeutics, LLC, Virttu Biologics Limited, Viventia Bio Inc., Welichem Biotech Inc. and Zhejiang BetaPharma Co., Ltd.







For more information:
•www.rnrmarketresearch.com/contacts/inquire-before-buying?…
•www.rnrmarketresearch.com/contacts/discount?rname=466322
•www.rnrmarketresearch.com/contacts/purchase?rname=466322
•www.rnrmarketresearch.com/liver-cancer-pipeline-review-h2…



News From


RnR Market ResearchRnR Market Research

Category: Market Research Reports

Company profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.